1. Home
  2. GHC vs PTCT Comparison

GHC vs PTCT Comparison

Compare GHC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graham Holdings Company

GHC

Graham Holdings Company

SELL

Current Price

$1,194.73

Market Cap

4.9B

Sector

Real Estate

ML Signal

SELL

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$60.45

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GHC
PTCT
Founded
1877
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.5B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
GHC
PTCT
Price
$1,194.73
$60.45
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
★ $100.33
AVG Volume (30 Days)
25.6K
★ 1.2M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
★ 0.63%
N/A
EPS Growth
N/A
★ 264.48
EPS
★ 71.04
0.90
Revenue
★ $2,932,099,000.00
$264,734,000.00
Revenue This Year
$5.98
N/A
Revenue Next Year
$4.03
$9.47
P/E Ratio
★ $16.86
$67.73
Revenue Growth
N/A
★ 36.19
52 Week Low
$974.00
$58.80
52 Week High
$1,262.35
$90.87

Technical Indicators

Market Signals
Indicator
GHC
PTCT
Relative Strength Index (RSI) 67.83 34.61
Support Level $1,104.70 N/A
Resistance Level $1,221.02 $68.93
Average True Range (ATR) 24.79 1.88
MACD 6.04 -0.15
Stochastic Oscillator 90.66 13.26

Price Performance

Historical Comparison
GHC
PTCT

About GHC Graham Holdings Company

Graham Holdings Company is a diversified holding company with operations spanning educational services, television broadcasting, healthcare, manufacturing, automotive dealerships, and other businesses. The Company's education activities are conducted through Kaplan, whose services include academic preparation programs for international students, English-language programs, exam preparation, and career and academic advisement. These services are provided to students, schools, and colleges, both domestically and outside the United States. It operates through seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, CSI, Manufacturing and Automotive, with key revenue coming from the Education and Automotive segments.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: